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ABSTRACT 
Schizotypy offers a useful construct for investigating the etiology, development, and expression 
of schizophrenia-spectrum psychopathology, as well as the comorbid expression of mood and 
anxiety disorders across the schizophrenia spectrum. The present study examined the 
associations of positive, negative, and disorganized schizotypy with affective symptoms and 
experiences in a sample of MTurk workers and college students (n=575). Participants completed 
the Multidimensional Schizotypy Scale (MSS) and measures of depression, anxiety, social 
phobia, hypomanic traits, and state affect. As expected, positive schizotypy was significantly 
associated with hypomanic traits, whereas negative schizotypy was associated with reduced 
positive affect and reduced hypomanic traits. Although prior research has emphasized the 
association of positive schizotypy with depression and anxiety, the current results demonstrate 
that disorganized schizotypy is more strongly associated with elevated negative affect (over-and-
above positive schizotypy). As such, these findings highlight the importance of examining 
disorganization of affect, in addition to the cognitive-behavioral deficits traditionally associated 
with disorganized schizotypy. Finally, the MSS and MSS-Brief demonstrated closely comparable 
findings. The present results provide further support for the construct validity of the MSS and the 
three-factor model of schizotypy. 
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 1 
INTRODUCTION 
 
SCHIZOPHRENIA AND SCHIZOTYPY 
Schizophrenia is a severe mental illness characterized by psychosis, negative symptoms, 
disordered thought and behavior, and marked functional deficits (American Psychiatric 
Association, 2013). Current models suggest that schizophrenia is the most extreme manifestation 
of a spectrum of clinical and subclinical impairment referred to as schizotypy (Kwapil and 
Barrantes-Vidal, 2015; Lenzenweger, 2010; Meehl, 1990). Schizotypy offers a useful construct 
as it encompasses subclinical manifestations, the psychosis prodrome, and schizophrenia-
spectrum disorders. The construct also provides a framework for investigating the etiology, 
development, and expression of schizophrenia-spectrum psychopathology (Kwapil and 
Barrantes-Vidal, 2015) without many of the confounds associated with clinical disorders (e.g., 
medication effects; Lenzenweger, 2006). Schizotypy and schizophrenia are heterogeneous, and 
this heterogeneity can be captured in a multidimensional structure that includes positive, 
negative, and disorganized dimensions (Kwapil and Barrantes-Vidal, 2015; Mason and Claridge, 
2006; Vollema and van den Bosch, 1995). Additionally, this multidimensional structure has been 
shown to be consistent across cultures (Fonseca-Pedrero et al., 2017; 2018). Positive schizotypy 
involves odd beliefs, unusual perceptual experiences, and suspiciousness. Negative schizotypy is 
characterized by diminished functioning such as affective flattening, anhedonia, avolition, 
anergia, and social withdrawal. Disorganized schizotypy is characterized by disturbances in 
thought, speech, and behavior. In addition to providing information about clinical manifestations 
of schizotypy, understanding the nature of this construct and its dimensions should enhance our 
identification of individuals at risk for developing schizophrenia-spectrum disorders.  
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SCHIZOTYPY AND AFFECTIVE EXPERIENCES 
Disruptions in the experience of emotion have been commonly implicated across the 
schizophrenia spectrum (as discussed below). Researchers have assessed affective symptoms in 
schizotypy, including the presence of depressive and anxious symptoms, as well as hypomanic 
traits. Further, differences in trait neuroticism and state affect have been observed. Assessment of 
these symptoms and experiences dimensionally in schizotypy provides information about 
patterns in the etiology and development of psychosis. 
 
Depression and anxiety 
Depressive and anxious symptoms are commonly present in patients with schizophrenia 
(American Psychiatric Association, 2013; Sands and Harrow, 1999). Specifically, evidence 
suggests higher lifetime prevalence of depressive (Häfner et al., 2005) and anxious (Cosoff and 
Hafner, 1998) symptoms and episodes in patients with schizophrenia-spectrum disorders than in 
the general population. Although depressive symptoms share several characteristics with 
negative symptoms of schizophrenia (e.g., anhedonia, diminished motivation), research suggests 
that these affective symptoms are more strongly associated with positive, or psychotic-like, 
symptoms than with negative symptoms (Drake et al., 2004; Emsley et al., 1999; Lysaker et al., 
1995).  
Multidimensional models of schizotypy show similar associations with affective and 
anxious symptoms as seen in schizophrenia. For example, Lenzenweger and Loranger (1989) 
found that positive schizotypy was associated with higher levels of anxiety and depression. 
Lewandowski et al. (2006) further demonstrated that symptoms of depression and anxiety are 
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more strongly associated with positive schizotypy than with negative schizotypy. Other 
researchers have indicated that individuals with both depressive and schizotypal features tend to 
demonstrate higher levels of paranoid and suspicious symptoms (Spitznagel and Suhr, 2004), 
which are conceptualized as core components of positive schizotypy. Likewise, social anxiety 
(Brown et al., 2008) and obsessive-compulsive symptoms (Einstein and Menzies, 2004; Norman 
et al., 1996; Sobin et al., 2000) are more strongly associated with positive schizotypy than with 
negative schizotypy. This is consistent with the conceptualization that negative schizotypy is 
characterized by diminished affective expression and processing (Kerns, 2006), and is likely 
associated with reduced vulnerability to the high negative affect that is typically associated with 
depression and anxiety.  
 
Mania and hypomania 
In addition to co-occurrence of depression and anxiety with positive schizotypy, evidence 
supports associations of manic and hypomanic symptoms with positive schizotypy. For example, 
approximately 50% of patients with bipolar I disorder experience psychotic symptoms in their 
lifetime (Goodwin and Jamison, 2007). Furthermore, schizophrenia and bipolar disorder tend to 
co-occur within families (Cardno and Owen, 2014). Positive, but not negative, schizotypy 
appears to be associated with risk for bipolar disorder and with hypomanic personality traits. 
Kwapil et al. (2013) reported that positive, but not negative, schizotypy predicted the 
development of manic or hypomanic episodes in the Chapmans’ ten-year longitudinal sample. In 
the derivation study of the Hypomanic Personality Scale (HPS), Eckblad and Chapman (1986) 
reported that scores on the HPS were significantly associated with positive schizotypy measures 
of magical ideation (r = .49) and perceptual aberrations (r = .43), but were inversely correlated 
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with a negative schizotypy measure of physical anhedonia (r = -.18). Unpublished data from 
1,594 college students assessed by our laboratory replicated these findings; scores on the HPS 
correlated .46 with positive schizotypy and -.10 with negative schizotypy (Kwapil and Kemp, 
2018).  
 
Neuroticism 
Models of personality traits, such as the Five-Factor Model, capture trait-like levels of 
emotional instability, depression, and anxiety in the personality dimension of neuroticism 
(McCrae and Costa, 2010). Neuroticism is elevated in patients with schizophrenia (Horan et al., 
2008). Traits such as neuroticism have the potential to interact with schizotypy and may provide 
information about the relationship between affective and schizophrenic symptoms. For example, 
Meehl (1990) suggested that personality vulnerabilities such as neuroticism may increase the 
likelihood of people with schizotypy decompensating into full-blown psychosis. Much like the 
established relationship among mood, anxiety, and positive schizotypy, studies have reported 
that positive, but not negative, schizotypy is strongly associated with neuroticism (Barrantes-
Vidal et al., 2009; Gross et al., 2014; Gross, Kwapil, Burgin et al., 2018; Kwapil et al., 2008; 
Kwapil, Gross, Burgin et al., 2018). Furthermore, neuroticism moderates the expression of 
schizotypy and may increase the likelihood of schizotypic individuals experiencing psychotic-
like symptoms and transitioning into schizophrenia-spectrum disorders (Claridge and Davis, 
2003). For example, Barrantes-Vidal et al. (2009) reported that neuroticism moderated the 
expression of positive, but not negative, schizotypy in the prediction of interview ratings of 
psychotic-like and schizotypal symptoms, as well as impaired functioning.  
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State affect 
In addition to examining trait-like affective experiences in schizotypy, studies have also 
assessed schizotypy in relation to state positive affect (PA) and negative affect (NA). For 
example, schizotypy is generally associated with lower levels of PA (Watson and Naragon-
Gainey, 2010) and higher levels of NA than healthy controls (Miller and Lenzenweger, 2014). 
PA and NA have also been assessed in daily life studies of schizotypy using experience sampling 
methodology (ESM). These studies have shown that the schizotypy dimensions are differentiated 
by their experience of affect in daily life. Specifically, positive schizotypy is associated with 
increased NA, whereas negative schizotypy is primarily associated with decreased PA 
(Barrantes-Vidal et al., 2013; Kwapil et al., 2012;). This is consistent with the relationship of 
mood and anxiety symptoms with schizotypy discussed above. 
Studies examining the association of affective symptoms and experiences with 
schizotypy have primarily focused on positive and negative schizotypy dimensions, but not 
disorganized schizotypy. Furthermore, studies that have examined disorganized schizotypy have 
often relied on measures that tap other constructs such as eccentricity or social anxiety. 
Disorganized schizotypy is presumed to involve disruptions in the ability to organize and 
regulate thoughts, affect, and behavior and is strongly associated with both neuroticism and 
positive schizotypy (e.g., Kwapil, Gross, Burgin et al., 2018). Therefore, it is essential to clarify 
the relationship of disorganized schizotypy and affective experiences.  
 
PSYCHOMETRIC ASSESSMENT OF SCHIZOTYPY 
Questionnaire measures have been widely used for assessing schizotypic characteristics 
and examining risk for developing schizophrenia-spectrum psychopathology (see reviews by 
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Chapman et al., 1995; Kwapil and Chun, 2015; Mason, 2015; Mason et al., 1997). Widely used 
measures of schizotypy include the Wisconsin Schizotypy Scales (WSS), which consist of the 
Perceptual Aberration (Chapman et al., 1978), Magical Ideation (Eckblad and Chapman, 1983), 
Physical Anhedonia (Chapman et al., 1976), and Revised Social Anhedonia (Eckblad et al., 
1982) Scales, the Schizotypal Personality Questionnaire (SPQ; Raine, 1991), and the Oxford-
Liverpool Inventory of Feelings and Experiences (O-LIFE; Mason et al., 1995). Brief versions 
have also been derived for each of these measures including the WSS-B (Winterstein et al., 
2011), SPQ-B (Raine and Benishay, 1995), and the O-LIFE-SV (Mason et al., 2005). Although 
these questionnaire measures of schizotypy have been widely employed, they suffer from a 
number of limitations including factor structures that are inconsistent with current conceptual 
models, outdated or biased items, and psychometric limitations.  
The Multidimensional Schizotypy Scale (MSS; Kwapil, Gross, Silvia, et al., 2018) and 
the Multidimensional Schizotypy Scale-Brief (MSS-B; Gross, Kwapil, Raulin et al., 2018) were 
developed to assess current conceptualizations of positive, negative, and disorganized schizotypy 
and to address the limitations associated with existing measures of schizotypy. Scale 
construction followed the recommendations of DeVellis (2012). Classical test theory, item 
response theory, and differential item functioning were employed to derive the 77-item MSS and 
the 38-item MSS-B. Both measures contain positive, negative, and disorganized schizotypy 
subscales. The MSS and MSS-B have good psychometric properties, good item discrimination, 
and minimal item bias for gender and race/ethnicity in large derivation (n = 6,265) and cross-
validation (n = 1,000) samples. Coefficient alpha reliabilities range from .88 to .94 for the MSS 
subscales (Kwapil, Gross, Silvia et al., 2018) and .78 to .90 for the MSS-B subscales (Gross, 
Kwapil, Raulin et al., 2018), and both the MSS and MSS-B subscales demonstrate good to 
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excellent test-retest reliability (Kemp et al., 2019). Furthermore, initial studies support the 
construct validity of the schizotypy subscales (e.g., Gross, Kwapil, Burgin et al., 2018; Kwapil, 
Gross, Burgin et al., 2018) and indicate comparable findings for the full-length and brief versions 
of the scale. However, studies have not examined the association of the MSS and MSS-B 
schizotypy dimensions with measures of affective experiences.  
 
GOALS AND HYPOTHESES 
The present study assessed the associations of positive, negative, and disorganized 
schizotypy with affective experiences including symptoms of depression, anxiety, social anxiety, 
hypomanic personality traits, and state positive and negative affect. To our knowledge, this is the 
first study to examine these associations using the MSS and the MSS-B positive, negative, and 
disorganized schizotypy subscales. We expected that the affective patterns in positive schizotypy 
and negative schizotypy would be comparable to those demonstrated in previous studies. Thus, 
we hypothesized that positive schizotypy would be strongly related to negative affect and 
symptoms of depression and anxiety, as well as hypomanic traits. Furthermore, we hypothesized 
that negative schizotypy would have a minimal relationship with negative affect and symptoms 
of depression and anxiety and would be inversely associated with hypomanic traits and positive 
affect. Although the relationship between disorganized schizotypy and affective experiences has 
not been widely examined, we expected that disorganized schizotypy would be moderately 
associated with measures of negative affect, depression, and anxiety due to the established 
relationship of disorganized schizotypy with neuroticism and positive schizotypy. Finally, we 
expected that the associations of the schizotypy dimensions and affective experiences would be 
closely comparable for the MSS and MSS-B. Specifically, we expected that magnitude of the 
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associations would not diminish when using the MSS-B relative to the MSS, as evidenced by the 
fact that the effect sizes for the correlations and regression coefficients from analogous analyses 
would be of the same magnitude for the MSS and MSS-B. Such findings would provide further 
support for the use of the MSS-B as an abbreviated form of the MSS. 
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METHODS 
 
PARTICIPANTS 
 Participants were recruited from two sources and completed online surveys via Qualtrics 
software. A total of 359 participants were recruited from across the United States through 
Amazon Mechanical Turk (MTurk) and 334 participants were recruited from the University of 
Illinois at Urbana-Champaign’s Psychology Department participant pool. All participants were at 
least 18 years of age. Participants were dropped for invalid responding or for completing the 
survey in less than 10 minutes. Usable data were retained for 293 MTurk participants (M age = 
38 years, SD = 11.3; 57% female; 8% Black, 4% Asian/Pacific Islander, 81% Caucasian, 5% 
Hispanic/Latino, <1% Native American, 1% other; 98% Native English speakers) and 282 
university participants (M age = 19.3 years, SD = 1.3; 62% female; 6% Black, 21% Asian/Pacific 
Islander, 51% Caucasian, 17% Hispanic/Latino, <1% Native American, 5% other; 83% Native 
English speakers). The total sample included 575 participants (M age = 28.8 years, SD = 12.4; 
60% female; 7% Black, 12% Asian/Pacific Islander, 67% Caucasian, 11% Hispanic/Latino, <1% 
Native American, 3% other; 91% Native English speakers). Information was not obtained 
regarding psychiatric diagnoses or treatment. 
 
MEASURES 
Multidimensional Schizotypy Scale 
The MSS contains 77 true-false items and the MSS-B contains 38 items that assess 
positive, negative, and disorganized schizotypy. The items are presented in Kwapil, Gross, Silvia 
et al. (2018) and Gross, Kwapil, Raulin et al. (2018). Note that scores on the MSS-B were 
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derived from the full-length MSS. Following recommendations of Kwapil, Gross, Silvia et al. 
(2018), separate scores were computed for each schizotypy dimension, as opposed to computing 
a total schizotypy score.  
 
Measures of affect and affective symptoms 
The 21-item Beck Depression Inventory-II (BDI; Beck et al., 1996) and the 21-item Beck 
Anxiety Inventory (BAI; Beck and Steer, 1993) assess the severity of recent depressive or 
anxiety symptoms, respectively. Note that one item assessing suicidal ideation was removed 
from the BDI at the request of the IRB. Items on the BDI and BAI share the same response 
format with responses ranging from 0 (no symptom endorsement) to 3 (severe symptom 
endorsement). The BDI has high coefficient-alpha reliability for patients with clinical depression 
(.92), as well as nonclinical individuals (.93; Beck, Steer, and Brown, 1996). The BAI has 
similarly high internal consistency (.92; Beck et al., 1988).  
The Social Phobia Scale (SPS) assesses the severity of social anxiety symptoms. It has 
good coefficient alpha reliability (.89; Mattick and Clarke, 1998). Responses are on a Likert 
scale ranging from 1 (“strongly disagree”) to 7 (“strongly agree”). The Positive and Negative 
Affect Schedule (PANAS; Watson, Clark, and Tellegen, 1988) contains 20 words that describe 
positive or negative emotions (e.g., “Excited”). Participants are instructed to indicate the extent 
to which they experienced the emotion within the last week on a scale of 1 (very slightly or not 
at all) to 5 (extremely). The PANAS has demonstrated high coefficient-alpha reliabilities in its 
assessment of both positive (.88) and negative affect (.87). 
 The Hypomanic Personality Scale (HPS; Eckblad and Chapman, 1986) is a self-report 
questionnaire that contains 48 true-false items that assess hypomanic personality traits. The HPS 
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has good coefficient-alpha reliability (.87) and test-retest reliability (.81). High scorers on the 
scale are at elevated risk for hypomanic and manic episodes (Kwapil et al., 2000; Walsh et al., 
2015).  
 
Infrequency Questionnaire 
A 13-item infrequency questionnaire (Chapman and Chapman, 1983) was included to 
screen out invalid responders. Following Chapman and Chapman, participants who endorsed 
more than two infrequency items were excluded from the analyses.  
  
PROCEDURES  
 Participants were recruited through MTurk and the university subject pool. All 
participants completed the questionnaires using the Qualtrics online survey system. The project 
received IRB approval from the University of Illinois at Urbana-Champaign and participants 
provided informed consent prior to completing the surveys. The survey began with demographic 
questions (age, sex, race/ethnicity, and English as first language). The MSS, HPS, and the 
infrequency questionnaire items (all true-false response) were intermixed and divided into five 
blocks. These five blocks were presented in random order after the demographic questionnaires. 
The remaining questionnaires (BDI, BAI, SPS, and PANAS) were then administered in random 
order. MTurk participants received $1 for completing the survey and university participants 
received course credit. 
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RESULTS 
 
DESCRIPTIVE STATISTICS 
 Descriptive statistics for the questionnaires are presented in Table 1. Note that descriptive 
statistics and coefficient alpha reliabilities from the MSS and MSS-B are comparable to results 
from previous samples. Likewise, the intercorrelations of the MSS and MSS-B subscales 
(presented in Table 2) are comparable to previous findings (Gross, Kwapil, Burgin et al., 2018; 
Kwapil, Gross, Burgin et al., 2018; Kwapil, Gross, Silvia et al., 2018). In general, each measure 
exhibited good to excellent internal consistency reliability. A total of 37 participants failed to 
complete 1 questionnaire item (out of 219 possible items), and 8 participants failed to complete 2 
items. The remaining 530 participants completed all of the items. 
 
ASSOCIATION OF MSS/MSS-B AND AFFECTIVE EXPERIENCES  
Table 2 presents the zero-order correlations of the MSS and MSS-B subscales and the 
measures of affective experiences (depressive and anxious symptoms, hypomanic personality, 
state PA and NA). Given the large sample size and number of analyses for this study, alpha was 
set to .001 in order to minimize Type I error and avoid interpreting miniscule effects as 
statistically significant. Effect sizes are noted in the tables following Cohen (1992). The 
correlations were closely comparable for the analogous MSS and MSS-B subscales. The 
measures of affective experiences tended to have their strongest association with disorganized 
schizotypy at the level of a medium or large effect.   
 In order to examine the unique association of the MSS and MSS-B schizotypy subscales 
with affective symptoms and experiences, we regressed each of the affective measure scores on 
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the three MSS and three MSS-B subscales (see Tables 3 and 4). Each row in the tables represent 
a separate regression analysis in which the three MSS or MSS-B subscales were entered 
simultaneously to examine their unique prediction of each of the affective experience scores. The 
standardized regression coefficient (β), change in R2, and effect size f2 are reported for each 
predictor in the linear regressions. Following Cohen (1992), f2 values above .15 are medium 
effect sizes, and above .35 are large effect sizes. Note that R2 and f2 were computed for each 
predictor by rerunning the analyses with the specific MSS predictor entered at the second step, 
over and above the other two MSS subscales. In order to examine the impact of multicollinearity, 
variance inflation factor (VIF) was computed for the three MSS and three MSS-B predictors, 
following Aiken et al. (2003). All VIF values were less than 1.3, indicating that multicollinearity 
did not adversely impact either set of regression analyses. 
The MSS and MSS-B positive schizotypy dimensions were significantly associated with 
hypomanic traits (medium effect size) and PA (small effect). The zero-order associations of 
positive schizotypy with measures of depressive and anxious symptoms and NA were better 
accounted for by disorganized than positive schizotypy in the regression analyses. Furthermore, 
the association of positive schizotypy with PANAS PA in the regression analysis (compared to 
the nonsignificant zero-order relation) appears to represent a suppression effect due to 
disorganized schizotypy, not negative schizotypy. Note that post hoc examination of the partial 
correlations of positive schizotypy and PA with disorganized schizotypy partialed out and 
negative schizotypy partialed out revealed that the suppression effect only occurred when 
partialing disorganized schizotypy.  
As expected, MSS and MSS-B negative schizotypy had significant inverse associations 
with hypomanic traits and PA. MSS negative schizotypy also had modest significant associations 
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with depression and social anxiety, whereas MSS-B negative schizotypy was not associated with 
social anxiety. In order to better understand the association of negative schizotypy and BDI 
scores, we examined the correlation of the individual BDI items with the MSS negative 
schizotypy score. Not surprisingly, the strongest correlations were with the BDI items “loss of 
interest” (r=.45), “loss of pleasure” (r=.43), and “loss of interest in sex” (r=.35). Note that when 
positive and disorganized schizotypy were partialed out of this analysis, none of the NA items on 
the BDI remained significantly correlated with negative schizotypy. Thus, the association of 
negative schizotypy with the BDI appears largely driven by items tapping loss of pleasure and 
interest in the world, not items tapping increased NA (see Supplemental Table 1). 
MSS disorganized schizotypy demonstrated the strongest association with affective 
experiences, over-and-above the other schizotypy dimensions. Specifically, it was associated 
with depressive and anxious symptoms (medium effect), social phobia symptoms (small effect), 
hypomanic traits (small effect), increased NA (medium effect), and decreased PA (small effect).  
In order to examine whether the associations of the MSS and MSS-B positive, negative, 
and disorganized subscales with the measures of affective symptoms and experiences differed in 
the MTurk and college student sample groups, we computed the positive schizotypy x group, 
negative schizotypy x group, and disorganized schizotypy x group interactions for each of the 
outcome measures. None of the interactions for the MSS (Supplemental Table 2) or the MSS-B 
(Supplemental Table 3) was significant, indicating that the associations of schizotypy and affect 
were comparable in the MTurk and college student samples. 
Although we did not offer specific hypotheses regarding sex differences in these 
associations, we recomputed the regression analyses with sex as a moderator variable. However, 
none of the sex by schizotypy dimension score interactions significantly predicted any of the 
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affect measures, indicating that the association of schizotypy dimensions with affect is invariant 
across sex (see Supplemental Tables 2 and 3).  
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DISCUSSION 
 
 Evidence suggests that mood and anxiety symptoms often co-occur with schizophrenia-
spectrum disorders (Cosoff and Hafner, 1998; Goodwin and Jamison, 2007; Häfner et al., 2005; 
Sands and Harrow, 1999) and this comorbidity can be observed across the continuum from 
subclinical schizotypy to clinically-identified schizophrenia (Brown et al., 2008; Eckblad and 
Chapman, 1986; Lenzenweger and Loranger, 1989; Lewandowski et al., 2006; Norman et al., 
1996; Spitznagel and Suhr, 2004). The presence of affective and anxiety symptoms has further 
implications for the presentation and course of schizophrenia-spectrum psychopathology. For 
example, positive symptoms in schizophrenia are often accompanied by mood and anxiety 
symptoms and are associated with better prognosis than negative symptoms in schizophrenia 
(Oosthuizen et al., 2002). Similarities in expression from schizotypy to schizophrenia suggest 
that studying affective symptoms in schizotypy can provide information about comorbidity in 
schizophrenia without the confounds of clinical populations.  
Previous research has assessed the relationship between schizotypy and affective 
experiences (e.g., Brown et al., 2008; Lewandowski et al., 2006), but these studies suffer from a 
number of limitations including outdated schizotypy measures and either exclusion of 
disorganized schizotypy or inclusion of problematic measures of disorganization. The present 
study is the first to examine the association of schizotypy with affective symptoms and 
experiences using the MSS and MSS-B. These measures offer the advantage of measuring 
positive, negative, and disorganized schizotypy based upon current conceptualizations of these 
dimensions. Although relatively new, the MSS and MSS-B have demonstrated good to excellent 
internal consistency, test-retest reliability, and initial construct validity.  
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 Our findings indicate several themes characterizing the relationship between the 
schizotypy dimensions and affective symptoms and experiences. First, disorganized schizotypy 
showed the strongest associations with affective and anxious symptoms and increased NA. Of 
note, however, hypomanic traits were strongly associated with positive schizotypy. This is 
consistent with current models that view positive symptoms and mania as overlapping constructs 
(Murray et al., 2004). The relationship between disorganized schizotypy and these experiences 
aligns with the conceptualization of disorganized schizotypy, as well as disorganized symptoms 
of schizophrenia. Specifically, disorganization is comprised of both cognitive and emotional 
dysregulation, though the former tends to be more typically emphasized (Bleuler, 1950; Kerns, 
2006). The experience of NA and related symptoms may be a direct response to cognitive 
dysregulation, and thus may be an important and overlooked aspect of disorganized schizotypy.  
 Second, disorganized schizotypy was associated with all experiences characterized by 
elevated NA (i.e., measures of affective symptoms and PANAS NA) over-and-above positive 
schizotypy. Previous studies have suggested that positive schizotypy is strongly associated with 
depression and anxiety (e.g., Brown et al., 2008; Lewandowski et al., 2006); however, the 
present study suggests that those zero-order findings are better explained by disorganized 
schizotypy. Note again that the measures used in previous studies failed to capture disorganized 
schizotypy. Therefore, these prior findings may be due to the moderate zero-order correlation 
between positive and disorganized schizotypy. Given this correlation, the factor linking these 
two dimensions may be affective dysregulation.  
 Thinking further about these relationships, it is important to consider how positive and 
disorganized schizotypy may be associated through features that perpetuate NA. Positive 
schizotypy is characterized by unusual thought content, odd perceptual experiences, and 
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suspiciousness, which may produce NA and associated experiences (as well as being driven or 
exacerbated by NA). For example, suspiciousness of other people may result in increased 
symptoms of social anxiety and distress. On the other hand, disorganized schizotypy involves 
disruptions in the ability to organize and regulate thought and affect that often may be conflated 
with positive schizotypy. Kerns (2005) noted that positive schizotypy was associated with 
reduced clarity of emotions.  However, this study only assessed the positive dimension of 
schizotypy; therefore, the findings may have been driven by the association between positive and 
disorganized schizotypy. Furthermore, deficits in clarity of emotion are associated with more 
cognitive difficulties under stress (Gohm et al., 2001). In this regard, affective dysregulation may 
link positive and disorganized schizotypy through cognitive difficulties in coping with stress, 
such as that generated from suspiciousness.  
Finally, negative schizotypy was strongly associated with reduced PA in the present 
study. This is in line with conceptualizations that anhedonia is a core component of negative 
schizotypy (e.g., Kwapil and Barrantes-Vidal, 2015). This finding is also consistent with 
previous work assessing state affect in daily life, which has indicated inverse relationships 
between negative schizotypy and state PA (e.g., Kwapil et al., 2012). Although negative 
schizotypy demonstrated a modest relationship with symptoms characterized by NA (i.e., 
depressive symptoms), follow-up analyses demonstrated that this association was relatively 
specific to items tapping anhedonic experiences of depression (i.e., reductions in PA) rather than 
NA itself. Thus, the relationship between negative schizotypy and depression may be best 
understood in terms of how negative schizotypy is traditionally conceptualized—as a diminution 
of affective expression and processing, including the experience of pleasure. 
Given that current conceptualizations of schizotypy include the three dimensions of 
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positive, negative, and disorganized schizotypy, the current study supports the use of the MSS 
and MSS-B in evaluating the differential associations of these dimensions. The alignment of 
these associations with current conceptualizations of schizotypy traits and deficits serves to 
further validate the MSS and MSS-B subscales. Furthermore, the results did not considerably 
differ between the MSS and MSS-B in either the zero-order correlations or the regression 
analyses, and the magnitude of effect sizes was comparable for all of the analogous analyses for 
the two versions of the scale. The correspondence of the findings between the MSS and MSS-B 
provides additional support for the validity of the MSS-B as a short form of the original MSS 
and builds upon previous validation studies that found comparable findings for the scales (e.g., 
Gross, Kwapil, Burgin et al., 2018; Kwapil, Gross, Burgin et al., 2018). 
Limitations of the current study include the use of retrospective self-report and a cross-
sectional design. However, given the personal nature of items that are unlikely to be observed by 
others (e.g., Occasionally I have felt as though my body did not exist), self-report provides an 
effective method for capturing these experiences. Note that schizotypy studies often are limited 
to only using college student samples. The inclusion of the MTurk subsample, along with the 
college student subsample, provided a more diverse sample in which to examine schizotypic 
characteristics and their relations with affective experiences. The present study used a cross-
sectional design to assess schizotypy and affective experiences; therefore, we are unable to 
determine the direction of causality in the reported relationships. Nevertheless, establishing a 
pattern of associations at one time provides information about the manifestation of these 
symptoms on the schizotypy continuum. Future studies should examine the developmental nature 
of these relationships using longitudinal study designs to establish temporal precedence. 
 In summary, this is the first study to our knowledge assessing relationships among the 
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MSS and MSS-B subscales and affective experiences and symptoms. In contrast to prior research 
evaluating schizotypy and these affective experiences, the current study provides evidence that 
disorganized schizotypy may better explain the relationship between positive schizotypy and NA 
and its associated symptoms. Although disorganized schizotypy is traditionally conceptualized as 
a cognitive-behavioral deficit in the schizophrenia spectrum, our research suggests that 
disorganization of affect may be a central and overlooked aspect of disorganized schizotypy and 
schizophrenia. The MSS and MSS-B demonstrated sensitivity in detecting the distinct 
associations of the schizotypy dimensions and affective experiences without conflating positive 
and disorganized schizotypy. Thus, the present study also provides support for use of both the 
MSS and MSS-B as valid measures of the construct schizotypy. 
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TABLES 
 
Table 1: Descriptive Statistics for the Multidimensional Schizotypy Scale, Multidimensional Schizotypy Scale-Brief, Beck Anxiety 
Inventory, Beck Depression Inventory, Social Phobia Scale, Hypomanic Personality Scale, and Positive and Negative Affect Schedule 
 
 
Criterion 
 
Mean 
 
S.D. 
 
Range 
Coefficient  
Alpha 
 
Skew 
Standard 
Error 
 
Kurtosis 
Standard 
Error 
Multidimensional Schizotypy Scale        
   Positive Schizotypy 2.53 3.46 0 – 26 .85 2.26 0.10 6.64 0.20 
   Negative Schizotypy 3.83 4.66 0 – 26 .89 1.88 0.10 3.89 0.20 
   Disorganized Schizotypy 3.61 5.28 0 – 25 .93 1.80 0.10 2.72 0.20 
         
Multidimensional Schizotypy Scale-Brief        
   Positive Schizotypy 1.30 1.80 0 – 13 .71 2.13 0.10 6.11 0.20 
   Negative Schizotypy 1.73 2.38 0 – 13 .80 1.98 0.10 4.10 0.20 
   Disorganized Schizotypy 1.56 2.61 0 – 12 .88 2.01 0.10 3.46 0.20 
         
Beck Depression Inventory 10.71 11.03 0 – 54 .94 1.24 0.10 1.04 0.20 
Beck Anxiety Inventory 10.01 10.38 0 – 56 .94 1.45 0.10 1.97 0.20 
Social Phobia Scale 61.74 25.83 19 – 130 .95 0.35 0.10 -0.69 0.20 
Hypomanic Personality Scale 14.24 8.39 0 – 41 .89 0.61 0.10 -0.13 0.20 
PANAS Positive Affect 30.05 8.28 10 – 50 .91 -0.05 0.10 -0.50 0.20 
PANAS Negative Affect 19.37 8.19 10 – 46 .91 0.88 0.10 0.11 0.20 
 
 
Note: PANAS = Positive and Negative Affect Schedule  
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Table 2: Correlations of the Multidimensional Schizotypy Scale, the Multidimensional Schizotypy Scale-Brief, Beck Depression 
Inventory, Beck Anxiety Inventory, Social Phobia Scale, Hypomanic Personality Scale, and Positive and Negative Affect Schedule (n 
= 575) 
 
     NegSz   DisSz    BDI    BAI    SPS HPS    PA   NA 
 
Multidimensional Schizotypy Scale;  
Multidimensional Schizotypy Scale-Brief 
       
   Positive Schizotypy (PosSz)  .17*/.16* .38*/.34* .22*/.17* .23*/.20* .20*/.18* .47*/.45* .01/.04 .22*/.16* 
   Negative Schizotypy (NegSz)   .34*/.36* .36*/.33* .16*/.14 .29*/.26* -.06/-.11 -.39*/-.36* .16*/.15* 
   Disorganized Schizotypy (DisSz)    .59*/.55* .46*/.44* .43*/.42* .37*/.34* -.33*/-.32* .47*/.44* 
Beck Depression Inventory (BDI)     .65* .46* .24* -.50* .68* 
Beck Anxiety Inventory (BAI)      .44* .29* -.30* .71* 
Social Phobia Scale (SPS)       .03 -.29* .41* 
Hypomanic Personality Scale (HPS)        .16* .29* 
PANAS Positive Affect (PA)         -.28* 
PANAS Negative Affect (NA)          
 
*p < .001 
Note: Multidimensional Schizotypy Scale correlations on left, Multidimensional Schizotypy Scale-Brief correlations on right 
Medium effect sizes in bold, large effect sizes in bold and italics 
PANAS = Positive and Negative Affect Schedule 
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Table 3: Linear Regressions Examining Prediction by the Multidimensional Schizotypy Scale Factors (n = 575) 
 
 MSS-Positive Schizotypy MSS-Negative Schizotypy MSS-Disorganized Schizotypy  
Criteria: β ΔR2 f2 β ΔR2 f2 β ΔR2 f2 Total R2 
           
BAI .063 .003 .004 -.006 .000 .000 .437* .147 .187 .214* 
BDI -.018 .000 .000 .181* .029 .046 .531* .218 .350 .373* 
SPS .038 .001 .001 .163* .023 .030 .358* .099 .125 .209* 
HPS .395* .133 .193 -.229* .046 .067 .298* .069 .100 .310* 
PANAS PA .181* .028 .036 -.315* .087 .112 -.294* .067 .085 .221* 
PANAS NA .049 .002 .003 -.001 .000 .000 .451* .157 .202 .222* 
 
*p < .001 
Note: medium effect sizes (f2) in bold 
BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; SPS = Social Phobia Scale; HPS = Hypomanic Personality Scale; 
PANAS PA/NA = Positive and Negative Affect Schedule Positive Affect/Negative Affect 
Each row represents a separate regression analysis in which the three MSS factors were entered simultaneously as predictors to 
examine their unique prediction of each affective measure score 
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Table 4: Linear Regressions Examining Prediction by the Multidimensional Schizotypy Scale-Brief Factors (n = 575) 
 
 MSS-Positive Schizotypy MSS-Negative Schizotypy MSS-Disorganized Schizotypy  
Criteria: β ΔR2 f2 β ΔR2 f2 β ΔR2 f2 Total R2 
           
BAI .061 .003 .004 -.020 .000 .000 .426* .144 .179 .197* 
BDI -.026 .001 .001 .155* .021 .031 .505* .202 .300 .326* 
SPS .042 .002 .002 .123 .013 .017 .357* .101 .124 .188* 
HPS .383* .130 .177 -.170* .025 .034 .271* .058 .079 .266* 
PANAS PA .179* .028 .035 -.292* .074 .092 -.273* .059 .074 .199* 
PANAS NA .017 .000 .001 -.008 .000 .000 .435* .150 .186 .193* 
 
*p < .001 
Note: medium effect sizes (f2) in bold 
BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; SPS = Social Phobia Scale; HPS = Hypomanic Personality Scale; 
PANAS PA/NA = Positive and Negative Affect Schedule Positive Affect/Negative Affect 
Each row represents a separate regression analysis in which the three MSS factors were entered simultaneously as predictors to 
examine their unique prediction of each affective measure score 
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APPENDIX A: SUPPLEMENTAL TABLES  
 
The supplementary file “Supplemental Tables” includes tables of additional results from 
exploratory analyses.  
 
Supplemental Table 1: Correlations and Partial Correlations of the MSS Negative Schizotypy 
Subscale with the Beck Depression Inventory Items 
 
BDI Item  
Zero-order 
correlation 
Partial      
correlation 
BDI 01 Sadness .25* .11 
BDI 02 Pessimism .30* .21* 
BDI 03 Past Failure .28* .17* 
BDI 04 Loss of Pleasure .43* .33* 
BDI 05 Guilty Feelings .21* .08 
BDI 06 Punishment Feelings .24* .12 
BDI 07 Self-Dislike .25* .15 
BDI 08 Self-Criticalness .18* .06 
BDI 10 Crying .11 -.01 
BDI 11 Agitation .18* .08 
BDI 12 Loss of Interest .45* .36* 
BDI 13 Indecisiveness .23* .06 
BDI 14 Worthlessness .30* .17* 
BDI 15 Loss of Energy .33* .20* 
BDI 16 Changes in Sleeping Pattern .17* .05 
BDI 17 Irritability .24* .14 
BDI 18 Changes in Appetite .11 -.02 
BDI 19 Concentration Difficulty .20* -.01 
BDI 20 Tiredness or Fatigue .28* .13 
BDI 21 Loss of Interest in Sex .35* .30* 
 
*p < .001 
Partial correlations of MSS Negative Schizotypy subscale and BDI items with MSS Positive and 
Disorganized Schizotypy subscales partialed out
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Supplemental Table 2: Multidimensional Schizotypy Scale Subscale by Sample Group Interaction Analyses 
 Step 1  Step 2  Step 3  
 MSS Positive MSS Negative  MSS Disorganized Group Pos x Group Neg x Group Dis x Group 
Criteria: β β β β β β β 
        
BAI .063 -.006 .437* -.189* -.034 .079 .036 
BDI -.018 .181 .531* -.110 -.021 .049 .006 
SPS .038 .163* .358* .032 .005 .048 .054 
HPS .395* -.229* .298* -.186* .041 -.015 .026 
PANAS PA .181* -.315* -.294* .062 .034 -.091 -.033 
PANAS NA .049 -.001 .451* -.351* -.024 .064 .000 
*p < .001 
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Supplemental Table 3: Multidimensional Schizotypy Scale-Brief Subscale by Sample Group Interaction Analyses 
 Step 1  Step 2  Step 3  
 MSS-B Positive MSS-B Negative  MSS-B Disorganized Group Pos x Group Neg x Group Dis x Group 
Criteria: β β β β β β β 
        
BAI .061 -.020 .426* -.203* -.032 .023 .069 
BDI -.026 .155 .505* -.122* -.017 .035 .021 
SPS .042 .123 .357* .027 .024 .035 .031 
HPS .383* -.170* .271* -.224* .034 -.028 .045 
PANAS PA .179* -.292* -.273* .056 .024 -.115 -.005 
PANAS NA .017 -.008 .435* -.364* -.023 .057 .006 
*p < .001 
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Supplemental Table 4: Multidimensional Schizotypy Scale Subscale by Sex Interaction Analyses 
 Step 1  Step 2  Step 3  
 MSS Positive MSS Negative  MSS Disorganized Sex Pos x Sex Neg x Sex Dis x Sex 
Criteria: β β β β β β β 
        
BAI .063 -.006 .437* .141* .010 -.014 .042 
BDI -.018 .181 .531* .072 .034 -.005 .005 
SPS .038 .163* .358* .193* -.025 -.019 .005 
HPS .395* -.229* .298* -.079 .015 .058 .000 
PANAS PA .181* -.315* -.294* -.080 -.025 .067 .002 
PANAS NA .049 -.001 .451* .123* .055 -.006 -.015 
*p < .001 
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Supplemental Table 5: Multidimensional Schizotypy Scale-Brief Subscale by Sex Interaction Analyses 
 Step 1  Step 2  Step 3  
 MSS-B Positive MSS-B Negative  MSS-B Disorganized Sex Pos x Sex Neg x Sex Dis x Sex 
Criteria: β β β β β β β 
        
BAI .061 -.020 .426* .144* .008 -.006 .038 
BDI -.026 .155 .505* .077 .050 -.001 .000 
SPS .042 .123 .357* .192* .002 -.024 .013 
HPS .383* -.170* .271* -.081 -.011 .079 -.019 
PANAS PA .179* -.292* -.273* -.087 -.047 .087 -.004 
PANAS NA .017 -.008 .435* .128* .057 .021 -.025 
*p < .001 
 
 
